|
|
|
|
CHARACTERIZATION OF THE DIRECT ANTIVIRAL EFFECT OF REP 2139 IN 2D AND 3D HDV INFECTION MODELS
|
|
|
AASLD 2024 Nov 15-19 San Diego
S FONTE 1,2, ML PLISSONNIER 1,2, M MICHELET 1,2, A ROCA SUAREZ 1,2, A VAILLANT 3, M LEVRERO 1,2,4,5,6
1 IHU Lyon - Institute d'Hépatologie de Lyon, Lyon, France; 2 PathLiv UNIT UCLB1 & INSERM, Lyon, France; 3 Replicor Inc., Montreal, Canada; 4 Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France; 5 University of Lyon Claude Bernard 1 (UCLB1), Lyon, France; 6 Department of Medicine SCIAC and the Italian Institute of Technology (IIT) Center for Life Nanosciences (CLNS), University of Rome La Sapienza, Rome, Italy
|
|
|
|
|
|
|